Clinical Trials Browser

Phase 1/2 × Aromatase Inhibitors × 90 days × Clear all

NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

Phase 1/2 Not yet recruiting

Breast Neoplasms, Sexual Dysfunctions, Psychological